Short Summary
NormShield and BitSight have jointly moved to terminate IPR2024-01393 following a settlement agreement. The Board has not yet issued an institution decision, and the parties argue that early termination saves costs and resources.
Detailed Summary
In IPR2024-01393 concerning U.S. Patent No. 9,973,524, NormShield Inc. (doing business as Black Kite Inc.) and BitSight Technologies, Inc. have filed a joint motion to terminate the inter partes review. Citing 35 U.S.C. § 317 and related regulations, the parties note that no institution decision has been rendered and that terminating the proceeding at this early stage promotes efficiency and minimizes unnecessary expenses. The motion is supported by a confidential settlement agreement between the parties, and they request that the Board grant the termination while keeping the settlement confidential.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in NormShield Inc. (d/b/a Black Kite Inc.) vs BitSight Technologies, Inc. is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Amazon.com, Inc. et al.vsNokia Technologies Oy
Amazon and Nokia filed a joint motion to terminate four IPRs after reaching a settlement. The Board granted the termination and ordered the settlement documents to be kept confidential.
Amphenol CorporationvsCredo Technology Group Ltd.
Amphenol and Credo have settled all disputes over U.S. Patent No. 11,032,111 and jointly moved to terminate the inter partes review. The Board is asked to dismiss the proceeding under 35 U.S.C. §317(a).
Kahoot! AS et al.vsinterstellar inc.
The USPTO denied Kahoot!’s request for Director Review of the decision that refused to institute an IPR against Interstellar’s patent. The denial leaves the original institution denial intact.
Astera Manufacturing Limited et al.vsElectraLED Inc.
Astera Manufacturing and Chauvet & Sons have filed an IPR petition seeking cancellation of claims 21‑28 of ElectraLED’s U.S. Pat. No. 7,651,245, alleging anticipation and obviousness over multiple LED‑lighting prior‑art references.
Tempus AI, Inc.vsGuardant Health Inc.
The PTAB affirmed Guardant Health’s patent on cfDNA tagging methods, finding none of the 29 challenged claims unpatentable after rejecting Tempus AI’s obviousness arguments.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.